Page last updated: 2024-11-07

n-(3,5-dichlorophenyl)-2-hydroxysuccinimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID114902
MeSH IDM0192021

Synonyms (7)

Synonym
ndhs
1-(3,5-dichlorophenyl)-3-hydroxypyrrolidine-2,5-dione
n-(3,5-dichlorophenyl)-2-hydroxysuccinimide
119341-82-1
1-(3,5-dichlorophenyl)-3-hydroxy-2,5-pyrrolidinedione
2,5-pyrrolidinedione, 1-(3,5-dichlorophenyl)-3-hydroxy-
DTXSID80922938

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" PB pretreatment also enhanced some monitored renal effects of a toxic dose (0."( Effect of microsomal enzyme modulators on N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS)-induced nephrotoxicity in the Fischer 344 rat.
Anestis, DK; Beers, KW; Brown, PI; Nicoll, DW; Rankin, GO, 1993
)
0.55
" At toxic levels in female rats, the renal lesions were located primarily in the S2 and S3 segments of the proximal tubule."( Gender differences in acute N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS) and N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid (2-NDHSA) nephrotoxicity in Fischer 344 rats.
Anestis, DK; Ball, JG; Brown, PI; Hong, SK; Rankin, GO; Valentovic, MA; Wang, RT, 1998
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's3 (23.08)29.6817
2010's1 (7.69)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]